BIO-key International Inc. (NASDAQ:BKYI) Sees Significant Drop in Short Interest

BIO-key International Inc. (NASDAQ:BKYI) was the target of a significant decline in short interest during the month of October. As of October 15th, there was short interest totaling 20,200 shares, a decline of 36.9% from the September 30th total of 32,000 shares. Based on an average daily volume of 127,500 shares, the short-interest ratio is currently 0.2 days. Approximately 0.4% of the shares of the company are sold short. Approximately 0.4% of the shares of the company are sold short. Based on an average daily volume of 127,500 shares, the short-interest ratio is currently 0.2 days.

BIO-key International Price Performance

Shares of BKYI opened at $0.78 on Friday. The firm has a market cap of $5.35 million, a PE ratio of -0.61 and a beta of 0.41. The stock’s fifty day moving average price is $0.77 and its two-hundred day moving average price is $0.79. BIO-key International has a 1 year low of $0.62 and a 1 year high of $3.68.

BIO-key International (NASDAQ:BKYI) last issued its earnings results on Wednesday, August 13th. The technology company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by ($0.05). The firm had revenue of $1.70 million during the quarter, compared to the consensus estimate of $1.70 million. BIO-key International had a negative net margin of 60.92% and a negative return on equity of 92.10%.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of BIO-key International in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has an average rating of “Sell”.

BIO-key International Company Profile

BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.